COVID-19 Vaccine Development

A SARS-CoV-2 vaccine would be a very powerful tool to slow down the COVID-19 pandemic. Well over a hundred vaccine candidates are in development, with some already being tested for safety and efficacy, or in phase I clinical trials. This feed follows the latest studies on vaccine design and development.

January 16, 2022
Preprint
Open Access

A prospective, single-center study to evaluate the clinical performance of Meril ABFind in individuals vaccinated against COVID-19

MedRxiv : the Preprint Server for Health Sciences
Jayanthi ShastriH. Gupta
January 16, 2022
Preprint
Open Access

Waning Effectiveness of SARS-CoV-2 mRNA Vaccines in Older Adults: A Rapid Review

MedRxiv : the Preprint Server for Health Sciences
E. NanishiA. Ozonoff
January 16, 2022
Preprint
Open Access

Distinct Vaccine Efficacy Rates Among Health Care Workers During a COVID-19 Outbreak in Jordan

MedRxiv : the Preprint Server for Health Sciences
Iyad SultanA. Mansour
January 16, 2022
Preprint
Open Access

Resilient T cell responses to B.1.1.529 (Omicron) SARS-CoV-2 variant

MedRxiv : the Preprint Server for Health Sciences
M. JergovicJanko Nikolich-Zugich
January 16, 2022
Preprint
Open Access

Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance

MedRxiv : the Preprint Server for Health Sciences
S. NasreenJeffrey C. Kwong
January 16, 2022

Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment.

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Alessio AmatuAndrea Sartore-Bianchi
January 16, 2022

Platelet and immune signature associated with a rapid response to the BNT162b2 mRNA Covid-19 Vaccine.

Journal of Thrombosis and Haemostasis : JTH
Davide FlegoVax-SPEED-IT Study Group
January 16, 2022
Open Access

Women's views on accepting COVID-19 vaccination during and after pregnancy, and for their babies: a multi-methods study in the UK.

BMC Pregnancy and Childbirth
Helen SkirrowBeth Holder
January 15, 2022
Preprint
Open Access

Validation of a clinical and genetic model for predicting severe COVID-19

MedRxiv : the Preprint Server for Health Sciences
Gillian S Dite Lifelines Corona Research Initiative
January 15, 2022
Preprint
Open Access

Comparison of Antibody Response Durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 Vaccines in Healthcare Workers

MedRxiv : the Preprint Server for Health Sciences
Wendy M BrunnerA. M. Gadomski
January 15, 2022

Waning antibody levels after COVID-19 vaccination with mRNA Comirnaty and inactivated CoronaVac vaccines in blood donors, Hong Kong, April 2020 to October 2021.

Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
Shirley Ll KwokJoseph T Wu
January 15, 2022
Open Access

Allergy to polyethylene glycol and polysorbates in a patient cohort: Diagnostic work-up and decision points for vaccination during the COVID-19 pandemic.

Clinical and Translational Allergy
Charlotte G MortzCarsten Bindslev-Jensen
January 15, 2022
Case Report

Post-COVID-19 Vaccine Parosmia: A Case Report.

Curēus
Osama S ZamzamiOsama A Marglani
January 15, 2022
Case Report

First Report of Acute Myocarditis Post-Pfizer-BioNTech COVID-19 Vaccination in the Kingdom of Bahrain.

Curēus
Tarique S ChacharManaf Alqahtani
January 15, 2022

Necessity of COVID-19 Vaccination in Persons Who Have Already Had COVID-19.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Nabin K ShresthaSteven M Gordon
January 15, 2022

Factors Affecting Initial Humoral Immune Response to SARS-Cov-2 Vaccines among Patients with Inflammatory Bowel Diseases.

The American Journal of Gastroenterology
Michael D KappelmanMillie D Long
January 15, 2022

Acute pancreatitis soon after COVID-19 vaccination: A case report.

Medicine
Sotaro OzakaKazunari Murakami

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Cardiovascular Complications

Growing evidence shows that COVID-19 can result in serious complications affecting the cardiovascular system, including dysrhythmias, myocarditis, acute myocardial infarction, and heart failure. This feed follows studies investigating the effects of SARS-CoV-2 infection on the heart.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

© 2022 Meta ULC. All rights reserved
/feed-previews/covid-19-vaccine-development/6282cef3-6d29-4262-ad8a-a937a12a89f9